HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS.

Abstract
Biomarkers could be useful in evaluating immune reconstitution inflammatory syndrome (IRIS). A cohort of 45 HIV-1-infected, antiretroviral treatment (ART)-naive patients with baseline CD4 T cell counts <or=100 cells/microL who were started on ART, suppressed HIV-RNA to <50 copies/mL, and seen every 1-3 months for 1 year were retrospectively evaluated for suspected or confirmed IRIS. d-Dimer, C-reactive protein (CRP), and selected autoantibodies were analyzed at baseline, 1 and 3 months post-ART in cryopreserved plasma. Median differences between cases and controls were compared with Mann-Whitney and Fisher's exact tests. Sixteen patients (35.6%) developed IRIS (median of 35 days post-ART initiation): unmasking=8, paradoxical=7, autoimmune=1. Pre-ART d-dimer and CRP were higher in IRIS cases versus controls (d-dimer: 0.89 mg/L versus 0.66 mg /L, p=0.037; CRP: 0.74 mg/L versus 0.39 mg/L, p=0.022), while d-dimer was higher in unmasking cases at IRIS onset (2.04 mg/L versus 0.36 mg /L, p=0.05). These biomarkers may be useful in identifying patients at risk for IRIS.
AuthorsBrian O Porter, G Laissa Ouedraogo, Jessica N Hodge, Margo A Smith, Alice Pau, Gregg Roby, Richard Kwan, Rachel J Bishop, Catherine Rehm, JoAnn Mican, Irini Sereti
JournalClinical immunology (Orlando, Fla.) (Clin Immunol) Vol. 136 Issue 1 Pg. 42-50 (Jul 2010) ISSN: 1521-7035 [Electronic] United States
PMID20227921 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright(c) 2010 Elsevier Inc. All rights reserved
Chemical References
  • Anti-Retroviral Agents
  • Autoantibodies
  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • HLA-A Antigens
  • fibrin fragment D
  • C-Reactive Protein
Topics
  • AIDS-Related Opportunistic Infections (complications, immunology)
  • Adult
  • Anti-Retroviral Agents (therapeutic use)
  • Autoantibodies (blood, immunology)
  • Biomarkers (blood)
  • C-Reactive Protein (metabolism)
  • CD4 Lymphocyte Count
  • Female
  • Fibrin Fibrinogen Degradation Products (metabolism)
  • HIV Infections (blood, drug therapy)
  • HIV-1 (isolation & purification)
  • HLA-A Antigens (genetics)
  • Humans
  • Immune Reconstitution Inflammatory Syndrome (blood, diagnosis, epidemiology, etiology)
  • Leukocyte Count
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: